0001237899-19-000038.txt : 20191213
0001237899-19-000038.hdr.sgml : 20191213
20191213180312
ACCESSION NUMBER: 0001237899-19-000038
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191211
FILED AS OF DATE: 20191213
DATE AS OF CHANGE: 20191213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fenimore Christopher R.
CENTRAL INDEX KEY: 0001697422
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 191285544
MAIL ADDRESS:
STREET 1: REGENERON PHARMACEUTICALS, INC.
STREET 2: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2019-12-11
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001697422
Fenimore Christopher R.
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
VP Controller
Common Stock
2019-12-11
4
A
0
1020
0.0
A
9697
D
Common Stock
2019-12-11
4
A
0
2500
0.0
A
12197
D
Common Stock
2019-12-12
4
M
0
3100
52.03
A
15297
D
Common Stock
2019-12-12
4
F
0
1418
377.16
D
13879
D
Common Stock
2019-12-13
4
S
0
191
374.82
D
13688
D
Common Stock
2019-12-13
4
S
0
624
375.58
D
13064
D
Common Stock
2019-12-13
4
S
0
470
376.27
D
12594
D
Common Stock
2019-12-13
4
S
0
346
377.38
D
12248
D
Common Stock
2019-12-13
4
S
0
51
378.27
D
12197
D
Common Stock
1401
I
By 401(k) Plan
Common Stock
1897
I
By Trust
Common Stock
509
I
by 2017 GRAT
Common Stock
2284
I
by 2018 GRAT
Non-Qualified Stock Option (right to buy)
52.03
2019-12-12
4
M
0
3100
0.0
D
2021-12-16
Common Stock
3100
7226
D
Non-Qualified Stock Option (right to buy)
372.46
2019-12-11
4
A
0
6120
0.0
A
2029-12-11
Common Stock
6120
6120
D
Award of Restricted Stock under the Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 11, 2021 and 50% on December 11, 2023.
Award of Restricted Stock under the Amended and Restated 2014 Long-Term Incentive Plan that vests in its entirety on December 11, 2023.
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 191 shares of Company stock on December 13, 2019 at prices ranging from $374.65 to $374.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 13, 2019 at each separate price.
Represents volume-weighted average price of sales of 624 shares of Company stock on December 13, 2019 at prices ranging from $375.05 to $375.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 13, 2019 at each separate price.
Represents volume-weighted average price of sales of 470 shares of Company stock on December 13, 2019 at prices ranging from $376.02 to $376.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 13, 2019 at each separate price.
Represents volume-weighted average price of sales of 346 shares of Company stock on December 13, 2019 at prices ranging from $377.09 to $377.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 13, 2019 at each separate price.
These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust.
The stock option award vests in four equal annual installments, commencing one year after the date of grant.
/s/**Christopher R. Fenimore
2019-12-13